CVST Symptoms Explained As 7 2m Johnson & Johnson COVID Vaccines Are Administered newsweek.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsweek.com Daily Mail and Mail on Sunday newspapers.
Gabrielle Lurie/The San Francisco Chronicle via Getty Images
Latest coronavirus news as of 5pm on 13 April
There have been six reports of rare blood clots among more than 6.8 million people in the US who received the Johnson & Johnson vaccine
US health authorities, including the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), recommended a pause in the use of the Johnson & Johnson covid-19 vaccine on 13 April as a precautionary measure, following reports of rare blood clots in six people who had received the vaccine. More than 6.8 million doses of the single-shot vaccine had been administered across the US as of 13 April. Among these, there were six reports of a rare blood clotting condition called cerebral venous sinus thrombosis (CVST), which affects blood vessels in the brain, all of which were among women aged 18 to 48. A special meeting of the CDC’s Advisory Committee on Immunization Practices will review the reports on 14 April,
Britain is still on track to offer a Covid-19 vaccine to all UK adults by the end of July – despite a pause in the rollout of the Janssen vaccine in Europe, officials have confirmed.
The UK has 30 million doses of the inoculation on order, but it has not yet been signed off for use by the Medicines and Healthcare products Regulatory Agency (MHRA).
The doses are expected to arrive in the second half of 2021 if approved by the regulator.
But the Department of Health and Social Care (DHSC) insisted Johnson & Johnson’s decision to delay the rollout of its vaccine in Europe would not derail the UK’s programme to offer a jab to all adults by the end of July.